MUNA MEDICAL UTILITY NETWORK ACCREDITOR
DEAD

Serial Number

90029109

Owner

Twin Acquisition Limited

Attorney

Michael G Shariff

Filing Date

Jun 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MUNA MEDICAL UTILITY NETWORK ACCREDITOR Trademark

Serial Number: 90029109

MUNA MEDICAL UTILITY NETWORK ACCREDITOR is a trademark filed by Twin Acquisition Limited on June 30, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Twin Acquisition Limited

Road Town, Tortola VG1110 , VG

Entity Type: 99

Trademark Details

Filing Date

June 30, 2020

Registration Date

Not Registered

Published for Opposition

December 21, 2021

Goods & Services

Downloadable software application for tracking, managing, and analyzing data for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; downloadable computer programs for tracking, managing, and analyzing data for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; downloadable software in the nature of a mobile application for tracking, managing, and analyzing data for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; downloadable software application for smartphones and tablet computers that allows users to receive data over a wireless communication network from a Polymerase Chain Reaction (PCR) testing system, save them and represent them in graphical format; downloadable software application for sending data and GPS coordinates via blockchain to a dedicated storage location in order to inform authorities about the presence of the infectious disease, and also for connecting with a Polymerase Chain Reaction (PCR) testing system in order to download testing data, plot the data, and/or automatically send the data via LTE network to a dedicated storage location for the purposes of monitoring the disease outbreak; electronic communications device for automatically uploading information over a wireless communication network to a smartphone and then wirelessly sending the information to a secure blockchain powered global network, instantly making the test results available anywhere in the world

Healthcare, wellness and medical services; medical services, namely, provision of clinical assessments, evaluations and diagnostic lab testing; providing healthcare, wellness information and public health information in connection with infectious disease and COVID-19; Medical testing for diagnostic or treatment purposes, namely, on-site testing for diagnosis and treatment of COVID-19, including both testing and analysis of test results; providing a website featuring medical information; providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the forgoing excluding information directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting; medical analysis services for diagnostic purposes; providing information relating to the testing and diagnosis of COVID-19, coronavirus, and other diseases; providing a website featuring news and information relating to the testing and diagnosis of COVID-19, coronavirus, and other diseases; charitable services, namely, providing medical devices and services for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases

Medical device and apparatus for use in the testing and diagnosis of COVID-19, coronavirus, and viruses; medical testing and diagnostic device and apparatus for the detection of COVID-19, coronavirus, and viruses; computerized medical recording and analysis apparatus for the diagnosis of COVID-19, coronavirus, and viruses; medical device and apparatus for use in the testing and diagnosis of COVID-19, coronavirus, and viruses, which also automatically uploads the testing information over a wireless communication network to a smartphone and then wirelessly sends the information to a secure blockchain powered global network, instantly making the test results available anywhere in the world

Providing online non-downloadable software to track, manage, and analyze data related to employee, customer and passenger health status; platform as a services (PaaS) featuring software for rapidly reviewing and analyzing COVID-19 test results, and communicating those results; scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the foregoing excluding medical research and scientific research consulting services directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting; medical and scientific research in the field of testing and diagnosis of COVID-19, coronavirus, and other diseases; software as a service (SAAS) services featuring software for tracking, managing, and analyzing data for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 16, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 16, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2024 EXRA
SOU EXTENSION 4 GRANTED
Feb 12, 2024 EX4G
SOU EXTENSION 4 FILED
Feb 12, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2023 EXRA
SOU EXTENSION 3 GRANTED
Aug 14, 2023 EX3G
SOU EXTENSION 3 FILED
Aug 14, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2023 EXRA
SOU EXTENSION 2 GRANTED
Feb 15, 2023 EX2G
SOU EXTENSION 2 FILED
Feb 15, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 15, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2022 EXRA
SOU EXTENSION 1 GRANTED
Aug 15, 2022 EX1G
SOU EXTENSION 1 FILED
Aug 15, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 15, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 21, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 1, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 18, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 18, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 18, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 18, 2021 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 17, 2021 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 14, 2021 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 10, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 9, 2021 GNFN
FINAL REFUSAL E-MAILED
Aug 9, 2021 GNFR
FINAL REFUSAL WRITTEN
Aug 9, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2021 GNRN
NON-FINAL ACTION E-MAILED
Feb 5, 2021 GNRT
NON-FINAL ACTION WRITTEN
Feb 5, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2020 NWOS
NEW APPLICATION ENTERED
Jul 3, 2020 NWAP